Skip to content

Definium Therapeutics

US · DFTX #2132 by market cap Listed 1970
28.34 -1.14 -3.87%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 14 analysts

Buy
Avg price target 74.31 +162.2%
Price target rangecurrent 28.34
Low55.00
Avg74.31
High91.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-12 JonesTrading -- Buy 90.00
2026-11-12 Maxim Group -- Buy 55.00
2026-11-11 Wells Fargo -- Buy 72.00
2026-11-10 CCORF -- Buy 78.00
2026-11-10 Piper Sandler -- Buy 75.00
2026-11-10 Needham -- Buy 66.00
2026-11-10 Oppenheimer -- Buy 75.00
2026-11-09 BofA Securities -- Buy 91.00
2026-11-09 H.C. Wainwright -- Buy 70.00
2026-11-09 RBC Capital -- Buy 70.00
2026-11-09 J.P. Morgan -- Buy --
2026-10-19 RBC Capital -- Buy 66.00
2026-10-09 J.P. Morgan -- Buy 84.00
2026-10-07 BofA Securities -- Buy 91.00
2026-09-19 LifeSci Capital -- Buy 78.00
2026-09-15 CCORF -- Buy 78.00
2026-09-15 JonesTrading -- Buy 90.00
2026-09-15 Maxim Group -- Buy 55.00
2026-09-15 Baird -- Buy 79.00
2026-09-15 Stifel -- Buy 67.00
2026-09-15 H.C. Wainwright -- Buy 70.00
2026-09-14 LifeSci Capital -- Buy 78.00
2026-09-14 BofA Securities -- Buy 91.00
2026-09-14 Needham -- Buy 66.00
2026-09-14 H.C. Wainwright -- Buy 70.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-09 After close ±12.85% -2.12% (in line)
2026/Q2 2026-08-06 After close ±23.43% +0.00% (in line)
2026/Q1 2026-05-07 After close ±10.00% -4.96% (in line)
2025/Q4 2026-02-26 After close ±12.30% +0.93% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.

Definium Therapeutics discussion 0 comments

Add a comment